Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PUMA BIOTECHNOLOGY, INC.

(PBYI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 776341408278--
Entreprise Value (EV)1 763324413224223151
P/E ratio -6,81x-4,49x-6,75x-27,6x-14,0x25,4x
Yield ------
Capitalization / Revenue 3,09x1,25x1,81x1,05x1,08x0,94x
EV / Revenue 3,04x1,19x1,83x0,84x0,86x0,51x
EV / EBITDA -8,73x-10,5x-20,3x19,8x51,7x2,87x
Price to Book ------
Nbr of stocks (in thousands) 38 13538 96139 76240 779--
Reference price (USD) 20,48,7510,36,826,826,82
Announcement Date 02/28/201902/20/202002/25/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 251272225266258297
EBITDA1 -87,3-31,0-20,411,34,3252,5
Operating profit (EBIT)1 -94,7-39,1-30,4-2,44-4,2519,6
Operating Margin -37,7%-14,4%-13,5%-0,92%-1,64%6,61%
Pre-Tax Profit (EBT)1 -114-75,6-59,8-9,73-24,8-17,4
Net income1 -114-75,6-60,0-1,69-11,5-5,80
Net margin -45,3%-27,8%-26,7%-0,63%-4,46%-1,96%
EPS2 -2,99-1,95-1,52-0,25-0,490,27
Dividend per Share2 ------
Announcement Date 02/28/201902/20/202002/25/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 52,698,253,455,160,290,4
EBITDA ------
Operating profit (EBIT)1 -11,320,2-16,6-8,36-4,7025,8
Operating Margin -21,5%20,6%-31,1%-15,2%-7,80%28,6%
Pre-Tax Profit (EBT)1 -15,016,5-5,10-11,5-5,85-
Net income1 -15,016,5-5,10-11,1-5,74-
Net margin -28,5%16,8%-9,55%-20,1%-9,54%-
EPS2 -0,380,40-0,13-0,29-0,240,56
Dividend per Share ------
Announcement Date 02/25/202105/06/202108/05/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 --4,92---
Net Cash position1 13,516,7-54,455,1127
Leverage (Debt / EBITDA) 0,16x0,54x-0,24x-4,82x-12,8x-2,43x
Free Cash Flow1 -24,722,10,7319,012,724,0
ROE (Net Profit / Equities) -259%-292%-1 042%7,50%-8,49%3,97%
Shareholders' equity1 43,825,95,76-22,5136-146
ROA (Net Profit / Asset) -53,5%-30,6%-25,0%1,79%-3,44%1,88%
Assets1 212247240-94,1334-309
Book Value Per Share ------
Cash Flow per Share2 -0,64-0,020,950,36-
Capex 0,610,310,05---
Capex / Sales 0,24%0,11%0,02%---
Announcement Date 02/28/201902/20/202002/25/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 278 112 984
Net sales (USD) 225 100 000
Number of employees 267
Sales / Employee (USD) 843 071
Free-Float 86,6%
Free-Float capitalization (USD) 240 770 736
Avg. Exchange 20 sessions (USD) 2 570 578
Average Daily Capital Traded 0,92%
EPS & Dividend
Change in Enterprise Value/EBITDA